AstraZeneca PLC
1688.50
21-May-24 10:29:37
15 minutes delayed
Stocks
+46.00
+2.80%
Today's range
1649.00 - 1692.50
ISIN
N/A
Source
NASD.OMX SE
-
AstraZeneca Q4 Profit Rises; Revenue Ex COVID-19 Up 16% At CER
08 Feb 2024 01:49:12 By NASDAQ US Markets
-
AstraZeneca's (AZN) sBLA for Enhertu Gets FDA's Priority Tag
30 Jan 2024 08:02:12 By NASDAQ Stocks
-
AstraZeneca: FDA Grants ENHERTU Priority Review For Metastatic HER2-Positive Solid Tumors
29 Jan 2024 07:32:09 By NASDAQ US Markets
-
AZN March 8th Options Begin Trading
25 Jan 2024 10:49:47 By NASDAQ Stocks
-
AstraZeneca Says AIRSUPRA Now Commercially Available In US As FDA-approved Option For Asthma
22 Jan 2024 06:32:47 By NASDAQ US Markets
-
Compugen To Receive $10 Mln Payment After Dosing First Patient In AstraZeneca's ARTEMIDE-Bil01 Trial
08 Jan 2024 07:09:47 By NASDAQ US Markets
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 10:38:29 By NASDAQ Stocks
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 10:34:42 By NASDAQ US Markets
-
Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program
02 Jan 2024 08:45:15 By NASDAQ US Markets
-
AstraZeneca To Buy Gracell For Up To $1.2 Bln
26 Dec 2023 02:23:07 By NASDAQ US Markets
-
AZN :FDA Oks Wainua For Treatment Of Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis
21 Dec 2023 19:47:36 By NASDAQ US Markets
-
AstraZeneca kicks off ‘new era of growth’ with aim to hit $80 billion of sales by 2030
21 Dec 2023 19:44:53 By MarketWatch
-
AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
12 Dec 2023 03:30:35 By Forbes - World
-
AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal
12 Dec 2023 02:42:28 By NASDAQ US Markets
-
AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH
10 Dec 2023 22:22:28 By NASDAQ US Markets
-
AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?
10 Dec 2023 08:09:34 By NASDAQ US Markets
-
Is Now the Right Time to Buy AstraZeneca Stock?
10 Dec 2023 06:46:15 By NASDAQ US Markets
-
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
05 Dec 2023 08:27:21 By NASDAQ Stocks
-
Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target
04 Dec 2023 07:12:31 By NASDAQ US Markets
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 Dec 2023 01:39:09 By NASDAQ US Markets